PHOSPHORYLATION OF CALMODULIN BY THE EPIDERMAL-GROWTH-FACTOR-RECEPTOR TYROSINE KINASE

被引:36
|
作者
BENGURIA, A
HERNANDEZPERERA, O
MARTINEZPASTOR, MT
SACKS, DB
VILLALOBO, A
机构
[1] CSIC, INST INVEST BIOMED, E-28029 MADRID, SPAIN
[2] BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 224卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1994.00909.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An epidermal-grow th-factor(EGF)-receptor preparation is elated by calmodulin-affinity chromatography from rat liver plasma membranes is able to phosphorylate calmodulin. Calmodulin phosphorylation was enhanced 3-8-fold by EGF, was dependent on the presence of a polycation or basic protein and was inhibited by micromolar concentrations of Ca2+. Phosphate incorporation into calmodulin occurs predominantly on tyrosine residues. Partial proteolysis of phosphocalmodulin by thrombin identifies Tyr99, located in the third calcium-binding domain of calmodulin, as the phosphorylated residue. Stoichiometric measurements show a P-32/calmodulin molar ratio of approximately 1 when optimal phosphorylation conditions are used.
引用
收藏
页码:909 / 916
页数:8
相关论文
共 50 条
  • [21] Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Jimeno, Antonio
    Hidalgo, Manuel
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02): : 217 - 229
  • [22] Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives
    Yang, EB
    Guo, YJ
    Zhang, K
    Chen, YZ
    Mack, P
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1550 (02): : 144 - 152
  • [23] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression Reply
    Morgan, Jeffrey A.
    Quek, Richard
    George, Suzanne
    Block, Susan D.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E51 - E51
  • [24] Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation
    Schooler, K
    Wiley, HS
    ANALYTICAL BIOCHEMISTRY, 2000, 277 (01) : 135 - 142
  • [25] Pharmacophore analysis of epidermal growth factor receptor tyrosine kinase inhibitors
    Peng, T
    Pei, JF
    Zhou, JJ
    ACTA CHIMICA SINICA, 2003, 61 (03) : 430 - 434
  • [26] Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy
    Raymond, E
    Faivre, S
    Armand, JP
    DRUGS, 2000, 60 (Suppl 1) : 15 - 23
  • [27] Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    James M. Rae
    Marc E. Lippman
    Breast Cancer Research and Treatment, 2004, 83 : 99 - 107
  • [28] Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC
    Pallis, A. G.
    Syrigos, K. N.
    LUNG CANCER, 2013, 80 (02) : 120 - 130
  • [29] Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor
    Liechti, C
    Séquin, U
    Bold, G
    Furet, P
    Meyer, T
    Traxler, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (01) : 11 - 26
  • [30] Thermal inactivation of the protein tyrosine kinase of the epidermal growth factor receptor
    Stein, RA
    Staros, JV
    BIOCHEMISTRY, 1996, 35 (09) : 2878 - 2884